073HO00792 JUBILANT

Print/PDF
Registration Name MEADOLAKE JUBILANT-ET
Registration Number HOCAN000000376455
Primary NAAB Code 073HO00792
Secondary Code(s)
Status Inactive
Controller Name Semex Alliance (200)
Date of Birth 9/14/1983
aAa -
DMS -
GFI 1.3%
Genetic Codes * RC TL TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T, HHR-C
Sire HANOVER-HILL TRIPLE THREAT-RED
MGS HOUSA000001646119
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ -1032, 89% R CM$ -1041
NM Percentile 01% FM$ -1018
GTPI 1114 GM$ -1096
PRODUCTION TRAITS
3199 Dtrs 1473 herds 100 % US 99% R
Milk -2155 Fat, % -66 , +0.10%
SCS 3.42, 99% R Protein, % -65 , +0.02%
Feed Saved -99 , 44% R Milking Speed 7.16 , 42% R
Health & Fertility
Productive Life -5.7      99% R Mastitis -0.1      79% R
Heifer Livability -0.1       50% R Metritis -1.6      71% R
Livability -1.9      96% R D. Abom -1.3      78% R
DPR -4.8      99% R Ketosis -1.5      68% R
FSC -18.4      98% R R. Placenta 0.7      72% R
HCR -3.3      86% R Milk Fever -0.4      48% R
CCR -5.4      97% R
SCR -        -
DIA 1.7      37% R
RSP 1.6      39% R
Calving Traits
Sire CE 2.8      99% R 707 Obs
Daughter CE 3.3      99% R 916 Obs, 532 Dtrs
Sire SB 4.9      99% R 261 Obs
Daughter SB 7.4      99% R 308 Obs, Dtrs
Gestation Length 3.7      90% R 9 Obs, 11 Dtrs
Early First Calving -7.1      98% R 1153 Obs, 2209 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
1675 Dtrs 861 herds 99% R
PTA Type -2.22 UDC -4.33
HCC -5.18 BWC 1.47
FLC -0.35
Linear Traits
Stature -0.60
Short
Strength 0.84
Weak
Body Depth 1.12
Deep
Dairy Form -1.50
Closed
Rump Angle -1.20
Flat
Thurl Width 1.21
Flat
Rear Legs-Side View 1.21
Wide
Rear Legs-Rear View -0.51
H.-in
Foot Angle -1.21
Low
Feet & Legs Score -0.38
Low
F.U. Attachment 0.04
Curved
Rear Udder Height -5.17
Low
Rear Udder Width -4.23
Narrow
Udder Cleft -2.35
Weak
Udder Depth -0.51
H.-in
Front Teat Placement -1.07
Wide
Rear Teat Placement -1.73
Wide
Teat Length 0.14
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO